The current financial score of Astrana Health Inc is 9.13. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 972.52M, representing a year-over-year increase of 48.52%, while its net profit experienced a year-over-year increase of 109.48%.
The current valuation score of Astrana Health Inc is 8.59. Its current P/E ratio is 55.81, which is 177.31% below the recent high of 154.77 and 56.56% above the recent low of 24.24.
The current earnings forecast score of Astrana Health Inc is 8.73. The average price target is 50.80, with a high of 65.00 and a low of 41.00.
The current price momentum score of Astrana Health Inc is 4.45. Currently, the stock price is trading between the resistance level at 38.47 and the support level at 31.74, making it suitable for range-bound swing trading.
The current institutional shareholding score of Astrana Health Inc is 5.00. The latest institutional shareholding proportion is 53.71%, representing a quarter-over-quarter decrease of 7.20%. The largest institutional shareholder is John Hussman, holding a total of 42.00K shares, representing 0.45% of shares outstanding, with 28.87% decrease in holdings.
The current risk assessment score of Astrana Health Inc is 6.62. The company's beta value is 1.01. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.